Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.
暂无分享,去创建一个
Joy Tan | Chonglei Bi | Norio Shimizu | Junli Yan | K. Aozasa | Junli Yan | Y. Kwong | W. Chng | Katsuyuki Aozasa | Wee-Joo Chng | Gaofeng Huang | J. Tan | Yok-Lam Kwong | N. Shimizu | Siok-Bian Ng | Gaofeng Huang | Viknesvaran Selvarajan | Jim Liang-Seah Tay | Baohong Lin | C. Bi | B. Lin | V. Selvarajan | S. Ng | J. Tay
[1] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Gaulard,et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. , 2010, Blood.
[3] L. Leoncini,et al. Role of EBV in microRNA dysregulation in Burkitt lymphoma. , 2009, Seminars in cancer biology.
[4] Hiroyuki Tagawa,et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. , 2009, Blood.
[5] M. Lutherborrow,et al. The clinicopathological relevance of microRNA in normal and malignant haematopoiesis , 2009, Pathology.
[6] T. Greiner,et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro , 2011, Leukemia.
[7] Thomas D. Schmittgen,et al. Increased expression of microRNA‐155 in Epstein‐Barr virus transformed lymphoblastoid cell lines , 2006, Genes, chromosomes & cancer.
[8] S. Nutt,et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance , 2006, Nature Immunology.
[9] D. Bartel,et al. MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.
[10] R. deLeeuw,et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies , 2009, Leukemia.
[11] Zhi-xiang Shen,et al. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. , 2008, Blood.
[12] Thomas Tuschl,et al. miRNAs in human cancer , 2011, The Journal of pathology.
[13] F. Slack,et al. MicroRNAs as potential cancer therapeutics , 2008, Oncogene.
[14] D. Heo,et al. MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma , 2011, Clinical Cancer Research.
[15] Kazuhiko Hayashi,et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.
[16] B. Klein,et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma , 1997, Nature Genetics.
[17] N. Rajewsky,et al. A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.
[18] Juan F. García,et al. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. , 2003, Haematologica.
[19] Karen Dybkær,et al. Genomic Analyses Reveal Global Functional Alterations That Promote Tumor Growth and Novel Tumor Suppressor Genes in Natural Killer-Cell Malignancies , 2008 .
[20] H. Drexler,et al. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. , 2003, Leukemia research.
[21] Burton B. Yang,et al. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression , 2007, Proceedings of the National Academy of Sciences.
[22] D. Brown,et al. The promise of microRNA replacement therapy. , 2010, Cancer research.
[23] M. Salto‐Tellez,et al. Activated oncogenic pathways and therapeutic targets in extranodal nasal‐type NK/T cell lymphoma revealed by gene expression profiling , 2011, The Journal of pathology.
[24] F. Slack,et al. Epstein-Barr virus-mediated dysregulation of human microRNA expression , 2008, Cell cycle.
[25] S. Carotta,et al. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. , 2011, Blood.
[26] K. Calame,et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function , 2006, Nature Immunology.
[27] Tsung-Cheng Chang,et al. Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.
[28] E. Izaurralde,et al. Gene silencing by microRNAs: contributions of translational repression and mRNA decay , 2011, Nature Reviews Genetics.
[29] Todd Wylie,et al. Next-generation sequencing identifies the natural killer cell microRNA transcriptome. , 2010, Genome research.
[30] Y. Matsuo,et al. p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization? , 2000, Leukemia.
[31] J. Cigudosa,et al. Mantle cell lymphoma: transcriptional regulation by microRNAs , 2010, Leukemia.
[32] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[33] M. Lacey,et al. MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Modulates Epstein-Barr Virus-Regulated Gene Expression Pathways , 2008, Journal of Virology.
[34] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.